Dendritic cell-based immunotherapy combined with antimony-based chemotherapy cures established murine visceral leishmaniasis

Journal of Immunology

Volumn 170, Issue 11, 2003, Pages 5625-5629

  Ghosh, Monidipa ^c   Pal, Chiranjib ^a   Ray, Mitali ^c   Maitra, Sudipta ^c   Mandal, Labanya ^c   Bandyopadhyay, Santu ^b  

^a BKC College   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; LIVER; MOUSE; NONHUMAN; PARASITE PREVALENCE; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; VACCINATION; VISCERAL LEISHMANIASIS;

EID: 0038528158     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.11.5625     Document Type: Article

References (28)

1. World Health Organization. 2000. Fact sheet no. 116. WHO, Geneva.
2. Sundar, S., A. K. Goyal, D. K. More. M. K. Singh, and H. W. Murray. 1998. Treatment of antimony-unresponsive Indian leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Ann. Trop. Med. Parasitol. 92:755.
3. Jha, T. K., S. Sundar, C. P. Thakur, P. Bachmann, J. Karbwang, C. Fischer, A. Voss, and J. Berman. 1999. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N. Engl. J. Med. 341:1795.
4. Murray, H. W., J. D. Berman, and S. D. Wright. 1998. Immunochemotherapy for intracellular Leishmania donovani infection: interferon-γ plus pentavalent antimony. J. Infect. Dis. 157:973.
5. Croft, S. L., R. N. Davidson, and E. A. Thornton. 1991. Liposomal amphotericin B in the treatment of visceral leishmaniasis. J. Antimicrob. Chemother. 28(Suppl. B):III.
6. Neal, R. A., and S. L. Croft. 1984. An in vitro system for determining activity of compounds against the intracellular form of Leishmania donovani. J. Antimicrob. Chemother. 14:463.
7. Murray, H. W., and S. Delph-Etienne. 2000. Roles of endogenous γ interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis. Infect. Immun. 68:288.
8. Steinman, R. M., and Z. A. Cohn. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1142.
9. Schuler, G., and R. M. Steinman. 1997. Dendritic cells as adjuvants for immunemediated resistance to tumors. J. Exp. Med. 186:1183.
10. Pardoll, D. M. 1998. Cancer vaccines. Nat. Med. 4:525.
11. Su, H., R. Messer, W. Whitmire, E. Fischer, J. C. Portis, and H. D. Caldwell. 1998. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J. Exp. Med. 188:809.
12. Bourguin, I., M. Moser, D. Buzoni-Gatel, F. Tielemans, D. Bout, J. Urbain, and O. Leo. 1998. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect. Immun. 66:4867.
13. Ahuja, S. S., R. L. Reddick, N. Sato, E. Montalbo, V. Kostecki, W. Zhao, M. J. Dolan, P. C. Melby, and S. K. Ahuja. 1999. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J. Immunol. 163:3890.
14. Moll, H., and C. Berberich. 2001. Dendritic cell-based vaccination strategies: induction of protective immunity against leishmaniasis. Immunobiology 204:659.
15. Ghosh, A. K., F. K. Bhattacharya, and D. K. Ghosh. 1985. Leishmania donovani: amastigote inhibition and mode of action of Berberine. Exp. Parasitol. 60:404.
16. + splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen. Immunology. 99:1.
17. Stauber, L. A., E. M. Franchino, and J. Grun. 1958. An eight day method for screening compounds against Leishmania donovani in the golden hamster. J. Protozool. 5:269.
18. Melby, P. C., Y. Z. Yang, J. Cheng, and W. Zhao. 1998. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani. Infect. Immun. 66:18.
19. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
20. Kawakami, K., M. Tohyama, X. Qifeng, and A. Saito. 1997. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of IL12. Infect. Immun. 65:1307.
21. Labeur, M. S., B. Roters, B. Pers, A. Mehling, T. A. Luger, T. Schwarz, and S. Grabbe. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:168.
22. Luther, S. A., H. L. Tang, P. L. Hyman, A. G. Farr, and J. G. Cyster. 2000. Co-expression of the chemokines ELC and SLC by T cell zone stromal cells and deletion of the ELC gene in the plt/plt mice. Proc. Natl. Acad. Sci. USA 97:12694.
23. Pathak, M. K., and T. Yi. 2001. Sodium stibogluclonate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. J. Immunol. 167:3391.
24. Murray, H. W., C. Montelibano, R. Peterson, and J. P. Sypek. 2000. Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis. J. Infect. Dis. 182:1497.
25. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
26. Dell'Albani, P., R. Santangelo, L. Torrisi, V. G. Nicoletti, J. de Vellis, and A. M. Giuffrida Stella. 2001. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J. Neurosci. Res. 65:417.
27. Rais, S., A. Perianin, M. Lenoir, A. Sadak, D. Rivollet, M. Paul, and M. Deniau. 2000. Sodium stibogluconate (Pentostam) potentiates oxidant production in murine visceral leishmaniasis and in human blood. Antimicrob. Agents Chemother. 44:2406.
28. Lee, N., S. Bertholet, A. Debrabant, J. Muller, R. Duncan, and H. L. Nakhasi. 2002. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 9:53.